搜尋結果
Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
Reuters· 5 小時前, opens new tab said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana ...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters· 9 小時前, opens new tab Ozempic slowed the worsening of kidney dysfunction in patients with type 2 ...
Weight-Loss Drug Zepbound May Also Treat Obstructive Sleep Apnea. Here’s What To Know About The ...
Forbes· 6 日前If shown to be effective, Zepbound could potentially be covered by Medicare in the future, ...
Low Carb撈嘢,High Fat揩嘢? | am730
am730· 23 小時前研究發現,限制脂肪攝取比限制碳水化合物攝取的飲食更有效減脂。 肥胖症,過去半個世紀不斷困擾著先進 ...
Exclusive | Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
The Wall Street Journal· 7 小時前The outlay to expand an Indiana production site, combined with a previous $3.7 billion ...
6 Trailblazing Female Founders In Women’s Healthcare
Forbes· 15 小時前Nearly half of all young American women have had negative experiences in healthcare settings. ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 1 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
Billionaire Jim Breyer Is Backing This Health AI Startup With A Radical Approach To Data
Forbes· 2 日前Doctors usually counsel people with diabetes not to abruptly switch or stop taking their ...
Is Real Estate Still A Safe Investment? Tips For Today's Market
Forbes· 4 日前Due to the quick jump in interest rates, many commercial real estate properties have ...
Genetic profile may predict best response to weight-loss drug Wegovy
Reuters· 5 日前The study, released at the Digestive Disease Week meeting in Washington, found a 95% likelihood ...